AMERIPRISE FINANCIAL INC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$49,789
+7.0%
83,010
+214.0%
0.00%
Q1 2023$46,529
-78.6%
26,437
-61.7%
0.00%
Q4 2022$217,000
-45.5%
69,073
-14.9%
0.00%
Q3 2022$398,000
+13.4%
81,181
-4.2%
0.00%
Q2 2022$351,000
-6.9%
84,763
+30.7%
0.00%
Q1 2022$377,000
-22.4%
64,872
+0.1%
0.00%
Q4 2021$486,000
+98.4%
64,831
+138.6%
0.00%
Q3 2021$245,000
-25.3%
27,175
-0.7%
0.00%
Q2 2021$328,000
-64.6%
27,379
-63.0%
0.00%
Q1 2021$926,000
-57.8%
73,912
-47.5%
0.00%
-100.0%
Q4 2020$2,196,000
+17.2%
140,733
-29.0%
0.00%0.0%
Q3 2020$1,874,000
+581.5%
198,308
+545.9%
0.00%
Q2 2020$275,000
+131.1%
30,701
+65.3%
0.00%
Q1 2020$119,000
-95.1%
18,570
-85.4%
0.00%
-100.0%
Q1 2018$2,420,000
+48300.0%
127,375
+30227.4%
0.00%
Q3 2014$5,000
+25.0%
420
+82.6%
0.00%
Q2 2014$4,000
+33.3%
230
+21.1%
0.00%
Q1 2014$3,0000.0%1900.0%0.00%
Q4 2013$3,000
-91.9%
190
-94.6%
0.00%
Q3 2013$37,000
+37.0%
3,5400.0%0.00%
Q2 2013$27,0003,5400.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders